to prevent delayed cardiomyopathy induced by adriamycin and subsequent severe congestive heart failure , a monitoring schedule with noninvasive techniques to measure cardiac performance ( cpk-mb , electrocardiographic , systolic time intervals , echocardiography and quantitative radionuclide angiography ) has been used .
C0018802
congestive heart failure
C0018787
cardiac